References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Akagi I, Ishibashi O. RNA-Seq analysis of human cell lines established from normal and neoplastic esophageal squamous epithelium. Genom Data. 2017;12:4–6. doi:https://doi.org/10.1016/j.gdata.2017.02.002
- Krug S, Michl P. Esophageal cancer: New insights into a heterogenous disease. Digestion. 2017;95(4):253–261. doi:https://doi.org/10.1159/000464130
- Liu M, Liu Z, Cai H, Guo C, Li X, Zhang C, Wang H, Hang D, Liu F, Deng Q, et al. A model to identify individuals at high risk for esophageal squamous cell carcinoma and precancerous lesions in regions of high prevalence in China. Clin Gastroenterol Hepatol. 2017;15(10):1538–1546-e7.:doi:https://doi.org/10.1016/j.cgh.2017.03.019
- Hamrah MH, Hamrah MS, Kanda M, Sakamoto J, Hamrah MH, Hami A, Hamrah AE, Dahi AE, Hamrah MH. Esophageal cancer and associated factors among Uzbek-Turkmen and other ethnic groups in the Northern Part of Afghanistan. Asian Pac J Cancer Prev. 2017;18(2):333–337. doi:https://doi.org/10.22034/APJCP.2017.18.2.333
- Bo Y, Lu Y, Zhao Y, Zhao E, Yuan L, Lu W, Cui L, Lu Q. Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis. Int J Cancer. 2016;138(8):1843–1850. doi:https://doi.org/10.1002/ijc.29838
- Cui L, Liu X, Tian Y, Xie C, Li Q, Cui H, Sun C. Flavonoids, flavonoid subclasses, and esophageal cancer risk: A meta-analysis of epidemiologic studies. Nutrients. 2016;8(6):350. doi:https://doi.org/10.3390/nu8060
- Takata Y, Xiang Y-B, Yang G, Li H, Gao J, Cai H, Gao Y-T, Zheng W, Shu X-O. Intakes of fruits, vegetables, and related vitamins and lung cancer risk: results from the Shanghai Men’s Health Study (2002–2009). Nutr Cancer. 2013;65(1):51–61. doi:https://doi.org/10.1080/01635581.2013.741757
- Ym N. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem. 2000;48(5):1150–1164.
- Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10A):58D–68D. doi:https://doi.org/10.1016/j.amjcard.2008.02.010
- Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications-a review. Mar Drugs. 2014;12(1):128–152. doi:https://doi.org/10.3390/md12010128
- Wakabayashi K, Hamada C, Kanda R, Nakano T, Io H, Horikoshi S, Tomino Y. Oral astaxanthin supplementation prevents peritoneal fibrosis in rats. Perit Dial Int. 2015;35(5):506–516. doi:https://doi.org/10.3747/pdi.2013.00317
- Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H, Tada N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010;209(2):520–523. doi:https://doi.org/10.1016/j.atherosclerosis.2009.10.012
- Dong LY, Jin J, Lu G, Kang XL. Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar Drugs. 2013;11(3):960–974. doi:https://doi.org/10.3390/md11030960
- Kowshik J, Nivetha R, Ranjani S, Venkatesan P, Selvamuthukumar S, Veeravarmal V, Nagini S. Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models. IUBMB Life. 2019;71(10):1595–1610. doi:https://doi.org/10.1002/iub.2104
- Li J, Dai W, Xia Y, Chen K, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, et al. Astaxanthin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells via inhibition of Nf-Κb P65 and Wnt/Β-catenin in vitro. Mar Drugs. 2015;13(10):6064–6081. doi:https://doi.org/10.3390/md13106064
- Kim MS, Ahn YT, Lee CW, Kim H, An WG. Astaxanthin modulates apoptotic molecules to induce death of SKBR3 breast cancer cells. Mar Drugs. 2020;18(5):266. doi:https://doi.org/10.3390/md18050266
- Peters JM, Shah YM, Gonzalez FJ. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer. 2012;12(3):181–195. doi:https://doi.org/10.1038/nrc3214
- Lu Z-h, Peng J-H, Zhang R-x, Wang F, Sun H-p, Fang Y-j, Wan D-S, Pan Z-Z. Dihydroartemisinin inhibits colon cancer cell viability by inducing apoptosis through up-regulation of PPAR gamma expression. Saudi J Biol Sci. 2018;25(2):372–376. doi:https://doi.org/10.1016/j.sjbs.2017.02.002
- Das Gupta S, Sae-Tan S, Wahler J, So JY, Bak MJ, Cheng LC, Lee M-J, Lin Y, Shih WJ, Shull JD, et al. Dietary γ-tocopherol-rich mixture inhibits estrogen-induced mammary tumorigenesis by modulating estrogen metabolism, antioxidant response, and PPARγ. Cancer Prev Res (Phila). 2015;8(9):807–816. doi:https://doi.org/10.1158/1940-6207.CAPR-15-0154
- Cao L-Q, Shao Z-L, Liang H-H, Zhang D-W, Yang X-W, Jiang X-F, Xue P. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression . Cancer Lett. 2015;359(1):127–135. doi:https://doi.org/10.1016/j.canlet.2015.01.004
- Ni J, Zhou L-L, Ding L, Zhao X, Cao H, Fan F, Li H, Lou R, Du Y, Dong S, et al. PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway. Exp Cell Res. 2017;361(2):246–256. doi:https://doi.org/10.1016/j.yexcr.2017.10.024
- Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V. The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer. PPAR Res. 2012;2012:242498 doi:https://doi.org/10.1155/2012/242498
- Sporn MB, Suh N, Mangelsdorf DJ. Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs). Trends Mol Med. 2001;7(9):395–400. doi:https://doi.org/10.1016/S1471-4914(01)02100-1
- Zhang X, Zhao WE, Hu L, Zhao L, Huang J. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells. Arch Biochem Biophys. 2011;512(1):96–106. doi:https://doi.org/10.1016/j.abb.2011.05.004
- Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y, Oki E, et al. Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer. Cancer Res. 2014;74(2):575–585. doi:https://doi.org/10.1158/0008-5472.can-13-1836
- Naguib YMA. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem. 2000;48(4):1150–1154. doi:https://doi.org/10.1021/jf991106k
- Choi HD, Kim JH, Chang MJ, Kyu-Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother Res. 2011;25(12):1813–1818. doi:https://doi.org/10.1002/ptr.3494
- Franceschelli S, Pesce M, Ferrone A, De Lutiis MA, Patruno A, Grilli A, Felaco M, Speranza L. Astaxanthin treatment confers protection against oxidative stress in U937 cells stimulated with lipopolysaccharide reducing O2-production. PLoS One. 2014;9(2):e88359. doi:https://doi.org/10.1371/journal.pone.0088359.g001
- Zhao W-e, Shi G, Gu H, Nguyen BN. Role of PPAR gamma; in the nutritional and pharmacological actions of carotenoids. Res Report Biochem. 2016;6:13–24. doi:https://doi.org/10.2147/rrbc.s83258
- Cimen I, Astarci E, Banerjee S. 15-lipoxygenase-1 exerts its tumor suppressive role by inhibiting nuclear factor-kappa B via activation of PPAR gamma. J Cell Biochem. 2011;112(9):2490–2501. doi:https://doi.org/10.1002/jcb.23174
- Ouyang L, Shi Z, Zhao S, Wang F-T, Zhou T-T, Liu B, Bao J-K. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45(6):487–498. doi:https://doi.org/10.1111/j.1365-2184.2012.00845.x
- Qian X, Tan C, Yang B, Wang F, Ge Y, Guan Z, Cai J. Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest. Dis Esophagus. 2017;30(6):1–7. doi:https://doi.org/10.1093/dote/dox027
- Hormozi M, Ghoreishi S, Baharvand P. Astaxanthin induces apoptosis and increases activity of antioxidant enzymes in LS-180 cells. Artif Cells Nanomed Biotechnol. 2019;47(1):891–895. doi:https://doi.org/10.1080/21691401.2019.1580286
- Chang CH, Chen KC, Liaw KC, Peng CC, Peng RY. Astaxanthin protects PC12 cells against homocysteine- and glutamate-induced neurotoxicity. Molecules. 2020;25(1):214. doi:https://doi.org/10.3390/molecules25010
- Rashidian G, Rainis S, Prokic MD, Faggio C. Effects of different levels of carotenoids and light sources on swordtail fish (Xiphophorus helleri) growth, survival rate and reproductive parameters. Nat Prod Res. 2020;1–12. doi:https://doi.org/10.1080/14786419.2020.1723091